Education
About Us
Working with TipRanks
Follow Us
PROCEPT BioRobotics (PRCT)
NASDAQ:PRCT
Total Valuation
PROCEPT BioRobotics has a market cap or net worth of $1.48B. The enterprise value is $1.18B.
Market Cap$1.48B
Enterprise Value$1.18B
Share Statistics
PROCEPT BioRobotics has 56,390,198 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding56,390,198
Owned by Insiders3.04%
Owned by Institutions18.15%
Financial Efficiency
PROCEPT BioRobotics’s return on equity (ROE) is -0.26 and return on invested capital (ROIC) is -23.48%.
Return on Equity (ROE)-0.26
Return on Assets (ROA)-0.19
Return on Invested Capital (ROIC)-23.48%
Return on Capital Employed (ROCE)-0.23
Revenue Per Employee407.48K
Profits Per Employee-126.42K
Employee Count756
Asset Turnover0.61
Inventory Turnover1.58
Valuation Ratios
The current PE Ratio of PROCEPT BioRobotics is ―. PROCEPT BioRobotics’s PEG ratio is 10.70.
PE Ratio―
PS Ratio5.69
PB Ratio4.79
Price to Fair Value4.79
Price to FCF-30.05
Price to Operating Cash Flow-30.22
PEG Ratio10.70
Income Statement
In the last 12 months, PROCEPT BioRobotics had revenue of 308.05M and earned -95.57M in profits. Earnings per share was -1.72.
Revenue308.05M
Gross Profit196.23M
Operating Income-103.86M
Pretax Income-95.38M
Net Income-95.57M
EBITDA-80.11M
Earnings Per Share (EPS)-1.72
Cash Flow
In the last 12 months, operating cash flow was -48.98M and capital expenditures -9.36M, giving a free cash flow of -58.34M billion.
Operating Cash Flow-48.98M
Free Cash Flow-58.34M
Free Cash Flow per Share-1.03
Dividends & Yields
PROCEPT BioRobotics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.03
52-Week Price Change-56.16%
50-Day Moving Average29.75
200-Day Moving Average40.29
Relative Strength Index (RSI)45.23
Average Volume (3m)1.70M
Important Dates
PROCEPT BioRobotics upcoming earnings date is Apr 30, 2026, After Close (Confirmed).
Last Earnings DateFeb 25, 2026
Next Earnings DateApr 30, 2026
Ex-Dividend Date―
Financial Position
PROCEPT BioRobotics as a current ratio of 6.85, with Debt / Equity ratio of 14.11%
Current Ratio6.85
Quick Ratio5.77
Debt to Market Cap0.03
Net Debt to EBITDA2.93
Interest Coverage Ratio-11.69
Taxes
In the past 12 months, PROCEPT BioRobotics has paid 190.00K in taxes.
Income Tax190.00K
Effective Tax Rate>-0.01
Enterprise Valuation
PROCEPT BioRobotics EV to EBITDA ratio is -18.95, with an EV/FCF ratio of -26.02.
EV to Sales4.93
EV to EBITDA-18.95
EV to Free Cash Flow-26.02
EV to Operating Cash Flow-30.99
Balance Sheet
PROCEPT BioRobotics has $286.50M in cash and marketable securities with $51.62M in debt, giving a net cash position of $234.89M billion.
Cash & Marketable Securities$286.50M
Total Debt$51.62M
Net Cash$234.89M
Net Cash Per Share$4.17
Tangible Book Value Per Share$6.55
Margins
Gross margin is 63.70%, with operating margin of -33.71%, and net profit margin of -31.02%.
Gross Margin63.70%
Operating Margin-33.71%
Pretax Margin-30.96%
Net Profit Margin-31.02%
EBITDA Margin-26.00%
EBIT Margin-28.08%
Analyst Forecast
The average price target for PROCEPT BioRobotics is $33.25, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$33.25
Price Target Upside25.19% Upside
Analyst ConsensusModerate Buy
Analyst Count10
Revenue Growth Forecast50.07%
EPS Growth Forecast21.22%